Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
Although antidepressants are generally effective in the treatment of major depressive disorder (MDD), it can still take weeks before patients feel the full antidepressant effects. Despite the efficacy of standard treatments, approximately two-thirds of patients with MDD fail to respond to pharmacoth...
Main Author: | Kenji Hashimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/4/7796 |
Similar Items
-
Neural Predictors of the Antidepressant Placebo Response
by: Danielle Rette, et al.
Published: (2019-10-01) -
Immunoregulation and antidepressant effect of ketamine
by: Zhang Nan, et al.
Published: (2021-05-01) -
The Ketamine Antidepressant Story: New Insights
by: Tahani K. Alshammari
Published: (2020-12-01) -
Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-04-01) -
Acute antidepressant effects of intramuscular versus intravenous ketamine
by: Harihar Chilukuri, et al.
Published: (2014-01-01)